Norges Bank’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Norges Bank’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11,399	Closed	-$69K	–	2131
2019 Q2	$69K	Sell	11,399 -181,159	-94%	-$963K	﹤0.01%	2093
2019 Q1	$1.12M	Hold	192,558	–	–	﹤0.01%	2046
2018 Q4	$2.59M	Hold	192,558	–	–	﹤0.01%	1986
2018 Q3	$3.74M	Hold	192,558	–	–	﹤0.01%	1997
2018 Q2	$4.92M	Hold	192,558	–	–	﹤0.01%	1952
2018 Q1	$3.88M	Hold	192,558	–	–	﹤0.01%	1926
2017 Q4	$3.87M	Buy	+192,558	New	+$3.79M	﹤0.01%	1902
2017 Q1	–	Sell	-89,785	Closed	-$1.13M	–	2210
2016 Q4	$1.13M	Sell	89,785 -29,269	-25%	-$545K	﹤0.01%	2028
2016 Q3	$3.19M	Buy	119,054 +43,000	+57%	+$1.44M	﹤0.01%	1938
2016 Q2	$2.66M	Buy	+76,054	New	+$2.39M	﹤0.01%	1976
2016 Q1	–	Sell	-100,904	Closed	-$3.45M	–	2218
2015 Q4	$3.45M	Hold	100,904	–	–	﹤0.01%	1942
2015 Q3	$2.9M	Buy	100,904 +90,904	+909%	+$3.89M	﹤0.01%	1982
2015 Q2	$448K	Hold	10,000	–	–	﹤0.01%	2191
2015 Q1	$346K	Buy	+10,000	New	+$272K	﹤0.01%	2231

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank's DPLO Position: Q3 2019 in Review

Norges Bank sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2019, closing a stake of 11,399 shares — an estimated $69K sold.

Norges Bank first reported a position in DPLO in Q1 2015 and held it in 14 quarters. The position peaked at $4.92M in Q2 2018. 137 funds tracked by Wall St. Rank hold DPLO as of Q3 2019.

Norges Bank reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2019 after selling out during the quarter.
Norges Bank sold 11,399 DIPLOMAT PHARMACY, INC. shares in Q3 2019, an estimated $69K.
Norges Bank first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 14 quarters.
Norges Bank's DIPLOMAT PHARMACY, INC. position peaked at $4.92M in Q2 2018.
137 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2019.

Based on Norges Bank's 13F filing for Q3 2019, filed 8 Nov 2019.